Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Regulatory-Grade External Controls
In our final session, we’ll explore how AI is revolutionizing clinical trials through predictive modeling and the use of synthetic and simulated patients. We’ll discuss digital twins, virtual cohort simulations, and how to integrate real-world evidence (RWE) into trial design.
Key Takeaways:
- The role of predictive AI in clinical trial design
- The use of virtual cohorts and digital twins for simulating outcomes
- Health authority perspectives on AI-generated evidence
Presenter: Billy Amzal, Ph.D., Head of Strategic Consulting, Phastar
